menu toggle
Christmas and New Year’s Day schedule
Cencora will be closed on Thursday, December 25 and Thursday, January 1 in observance of the Christmas and New Year’s Day holidays. There will be no deliveries on both of these days, and Customer Service and Customer Systems Support teams will be unavailable. Our hours of operation have also been modified for Christmas Eve and New Year’s Eve. Please closely review the holiday schedule dashboard for detailed schedule information, so you can plan your orders accordingly.
Review the holiday schedule
Action required: New logo and email address for invoices starting October 18
Ensure that you’re prepared to continue receiving invoices electronically.
Learn more

Outlook Therapeutics® and AmerisourceBergen Announce Strategic Commercialization Agreement for ONS-5010 for the Treatment of Wet AMD

ISELIN, N.J. and CONSHOHOCKEN, Pa., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a pre-commercial biopharmaceutical company working to develop and launch the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications, and AmerisourceBergen (NYSE: ABC), a global healthcare company and leader in specialty pharmaceutical distribution and services, announced today that they have entered into a strategic relationship in preparation for the anticipated commercial launch in the United States of ONS-5010 / LYTENAVA™ (bevacizumab-vikg), if approved by the U.S. Food and Drug Administration (FDA).

More in the Media

The DSCSA Clock Is Ticking

September 02, 2024

How Heat Waves Threaten the Pharma Cold Chain

August 19, 2024

Addressing Access and Affordability Issues With Collaboration at Asembia 2024

May 06, 2024

Understanding State Regulations and Advocating for Medically Integrated Dispensing

May 03, 2024